INTRODUCTION {#s1}
============

Lysosomes are dynamic, membrane-bound organelles that maintain a low luminal pH (pH~ly~ ∼4.5) ([@JCS223883C22]). More than fifty degradative enzymes within lysosomes allow them to degrade materials imported by endocytosis, and to recycle intracellular materials by autophagy ([@JCS223883C29]; [@JCS223883C44]). Lysosomes coordinate responses to nutrient deprivation through their ability to sense amino acids, and regulate the biogenesis of lysosomes and autophagy proteins ([@JCS223883C45]). They also mediate transfer of cholesterol and other lipids between membranes, and they contribute to membrane repair ([@JCS223883C53]). Lysosomes also sequester Ca^2+^ and express Ca^2+^-permeable channels, notably transient receptor protein mucolipin (TRPML1), two pore channel type 2 (TPC2, encoded by *TPCN2*) and ATP-regulated P~2~X~4~ receptor (P2RX4) ([@JCS223883C35]). These proteins allow Ca^2+^ to regulate lysosomal behaviour and allow lysosomes to contribute to cytosolic Ca^2+^ signalling ([@JCS223883C28]). There are, however, few pharmacological opportunities to disable lysosomes: inhibition of the lysosomal V-ATPase (with bafilomycin A~1~ or concanamycin A) allows the lysosomal pH gradient to be dissipated ([@JCS223883C13]), and glycyl-[l]{.smallcaps}-phenylalanine 2-naphthylamide ([l]{.smallcaps}-GPN, hereafter referred to as GPN) is widely used, purportedly to disrupt lysosomal membranes ([Fig. 1](#JCS223883F1){ref-type="fig"}A).

Many molecules, typically amphipathic weak bases, accumulate within lysosomes because they are sufficiently lipophilic at neutral pH to cross biological membranes, but at low pH~ly~ they are protonated and trapped in the lysosome lumen, where they can become highly concentrated ([@JCS223883C36]). These molecules, which include many drugs in clinical use, are described as 'lysosomotropic'. Accumulation of lysosomotropic molecules within lysosomes increases pH~ly~, and the high concentrations achieved can perturb lysosomal functions. Sphingosine, for example, concentrates within lysosomes, disrupting lipid domains and allowing molecules to leak across the membrane ([@JCS223883C58]).

Cathepsin C (CTSC, also known as dipeptidyl peptidase 1) is widely supposed to be expressed mainly within lysosomes ([@JCS223883C41]), where it cleaves a pair of N-terminal residues from its peptide substrates until it reaches a proline or basic residue. At neutral pH, cathepsin C can also polymerise dipeptides ([@JCS223883C31]; [@JCS223883C54]). These properties of cathepsin C have been exploited to allow selective disruption of lysosomes. For example, the esterified dipeptide, [l]{.smallcaps}-leucyl-[l]{.smallcaps}-leucine methyl ester (LLOMe, also known as Leu-Leu-OMe), disrupts lysosomes and, thereby, triggers apoptosis. The likely mechanism involves an initial lysosomotropic accumulation of LLOMe within lysosomes, causing pH~ly~ to increase; cathepsin C then catalyses polymerisation of the de-esterified dipeptide and, as the hydrophobic polymer accumulates, it perturbs the lysosomal membrane, rendering it permeable to small molecules (molecular mass\<10 kDa) ([@JCS223883C42]; [@JCS223883C54]).

GPN ([Fig. 1](#JCS223883F1){ref-type="fig"}A), another synthetic substrate of cathepsin C, has been used extensively to perturb lysosomes, with ∼100 publications reporting its use (e.g. [@JCS223883C6]; [@JCS223883C9]; [@JCS223883C10]; [@JCS223883C11]; [@JCS223883C12]; [@JCS223883C15]; [@JCS223883C16]; [@JCS223883C18]; [@JCS223883C24]; [@JCS223883C25]; [@JCS223883C32]; [@JCS223883C34]; [@JCS223883C39], [@JCS223883C38]; [@JCS223883C43]). It is assumed that GPN disrupts lysosomes because it is degraded within them by cathepsin C (hence, its selectivity for lysosomes); then the dipeptide accumulates, generating osmotic stress that ruptures lysosome membranes ([@JCS223883C6]). There is evidence (from release of dextran-conjugated fluorophores) that modified dipeptides can rupture lysosomes (e.g. [@JCS223883C42]), but many more papers mistakenly assume that loss of Acridine Orange or LysoTracker signifies rupture of lysosomes (e.g. [@JCS223883C57]). However, Acridine Orange and LysoTracker, like other lysosomotropic agents, will redistribute across intact lysosomal membranes when pH~ly~ increases.

The widespread use of GPN to acutely assess the Ca^2+^ content of lysosomes and the lack of evidence that these effects are mediated by cathepsin C encouraged us to assess both the mechanism of action of GPN and its selectivity for lysosomes. We show that GPN evokes a rapid and sustained increase in pH~ly~, and transient increases in cytosolic pH (pH~cyt~) and cytosolic free Ca^2+^ concentration (\[Ca^2+^\]~c~). None of these responses requires cathepsin C activity; neither are they accompanied by detectable rupture of lysosome membranes. Rather than selectively stimulating Ca^2+^ release form lysosomes, GPN increases \[Ca^2+^\]~c~ by causing an increase in pH~cyt~ that then stimulates Ca^2+^ release from the ER by a mechanism that requires neither inositol 1,4,5-trisphosphate (IP~3~) receptors nor ryanodine receptors.

RESULTS {#s2}
=======

GPN evokes pH changes and Ca^2+^ signals without rupturing lysosomes {#s2a}
--------------------------------------------------------------------

GPN is widely used to dissipate the lysosomal pH gradient and release Ca^2+^ from lysosomes (see Introduction) ([Fig. 1](#JCS223883F1){ref-type="fig"}A). In HEK cells, GPN caused a sustained increase in pH~ly~ and a transient increase in \[Ca^2+^\]~c~ ([Fig. 1](#JCS223883F1){ref-type="fig"}B-F, [Fig. S1A,B](Fig. S1A,B)). The Ca^2+^ signals evoked by GPN were slower than those evoked by carbachol, which stimulates IP~3~ formation and Ca^2+^ release through IP~3~ receptors (IP~3~Rs), but faster than those evoked by inhibiting the ER Ca^2+^ pumps (sarcoplasmic/endoplasmic reticulum Ca^2+^-ATPases, SERCAs) with cyclopiazonic acid (CPA) or thapsigargin ([Fig. 1](#JCS223883F1){ref-type="fig"}D,G, [Fig. S1C,D](Fig. S1C,D)). While these results are consistent with the reported actions of GPN, additional observations are not consistent with its presumed mode of action ([Fig. 1](#JCS223883F1){ref-type="fig"}A). Fig. 1.**GPN changes pH and \[Ca^2+^\]~c~ without rupturing lysosomes.** (A) GPN is proposed to disrupt lysosomes because its cleavage by cathepsin C (blue arrow) causes osmotic lysis. (B) HEK cells loaded with LysoTracker Red, or with dextran conjugates of Oregon Green or fluorescein report an increase in pH~ly~ after addition of GPN (200 µM for 200 s). Increased pH causes fluorescence to decrease for LysoTracker Red and increase for the other indicators. (C) Time courses of GPN-evoked changes in fluorescence (F/F~0~) of the pH~ly~ indicators. Each trace shows mean±s.d. from 3--4 ROIs in a single cell (summarised in [Fig. 3](#JCS223883F3){ref-type="fig"}F,H). (D) BAPTA (2.5 mM) was added to chelate extracellular Ca^2+^, and cyclopiazonic acid (CPA, 20 µM) to inhibit SERCAs, before the addition of GPN (200 µM) to fluo 8-loaded HEK cells. Results show mean±s.d. for 3 replicates. (E) Summary results (mean±s.e.m., *n*=3) from analyses similar to those in panel D show peak increase in \[Ca^2+^\]~c~ (Δ\[Ca^2+^\]~c~) evoked by GPN. \**P*\<0.05, Student\'s *t*-test. (F) Wild-type HEK cells (WT) or HEK cells without IP~3~Rs (IP~3~R-KO) kept in Ca^2+^-free HBS were either stimulated with 200 µM GPN alone or treated with 1 µM thapsigargin (TG) for 15 min followed by addition of 200 µM GPN. Results (mean±s.e.m., *n*=4, with 3 replicates) show Δ\[Ca^2+^\]~c~. The green symbols are obscured by the overlying blue symbols. (G) Initial responses of HEK cells to carbachol (CCh, 1 mM), GPN (200 µM) or thapsigargin (TG, 1 µM) in Ca^2+^-free HBS (mean±s.d. of 3 replicates). A summary of these data is shown in [Fig. S1C,D](Fig. S1C,D). (H) Effect of GPN (200 µM) on pH~cyt~ determined using the pH indicator SNARF-5F in populations of HEK cells. (I,J) Effects of bafilomycin A~1~ (Baf A~1~, 1 µM, 1 h) on basal pH~cyt~ (I) and on the ΔpH~cyt~ evoked by GPN (200 µM, 200 s) (J). Results (mean±s.e.m., *n*=5, each with 3 replicates) show no significant effect of BafA~1~ (Student\'s *t*-test). (K) Representative confocal images show that GPN (200 µM, 10 min) had no effect on the punctate distribution of endocytosed Lucifer Yellow (*M*~r~ 447) or Alexa Fluor 488-coupled dextran (*M*~r~ ∼10,000). (L) Number of lysosomes identified before (0 min) and 5 min after GPN addition in at least 3 cells per coverslip. Mean±s.e.m., *n*=3 independent coverslips (Alexa Fluor 488-Dx, top graph) and *n*=4 independent coverslips (Lucifer Yellow, bottom graph).

First, GPN caused a rapid and transient increase in cytosolic pH (pH~cyt~) ([Fig. 1](#JCS223883F1){ref-type="fig"}H). Rupture of acidic lysosomes would be expected to decrease pH~cyt~, as occurs, for example, when tumour necrosis factor alpha (TNFα) triggers loss of H^+^ and cathepsin D from lysosomes during the early stages of apoptosis ([@JCS223883C37]). Similarly transient increases in pH~cyt~ were observed in other cell types and with different sources of GPN ([Fig. S1E,F](Fig. S1E,F)). Dissipation of the lysosomal pH gradient by inhibiting the V-ATPase with bafilomycin A~1~ had no effect on basal pH~cyt~ or the subsequent GPN-evoked increase in pH~cyt~ ([Fig. 1](#JCS223883F1){ref-type="fig"}I,J). These results show that H^+^ within lysosomes does not contribute to GPN-evoked changes in pH~cyt~. Since Ca^2+^ indicators are pH-sensitive (see [@JCS223883C51]), we confirmed that the affinity of fluo 8 for Ca^2+^ was unaffected by changing pH between 7 and 8 ([Fig. S2](Fig. S2)), indicating that the GPN-evoked increases in fluo 8 fluorescence are due to an increase in \[Ca^2+^\]~c~ ([Fig. 1](#JCS223883F1){ref-type="fig"}D-F).

Second, the acute effects of GPN on pH~ly~ and pH~cyt~ were not accompanied by loss of endocytosed fluorescent molecules with molecular masses ranging from 447 (Lucifer Yellow), through ∼3 kDa (fluorescein-dextran) to ∼10 kDa (dextran conjugates of Alexa Fluor 488 and Oregon Green) ([Fig. 1](#JCS223883F1){ref-type="fig"}B,K,L, [Fig. S1G](Fig. S1G)). These results are not consistent with the effects of GPN on pH or \[Ca^2+^\]~c~ arising from rupture of lysosomes. More prolonged incubations with GPN (\>10 min) caused some loss of lysosomal Alexa Fluor 488-dextran but, even after 25 min, most was retained by lysosomes ([Fig. S3](Fig. S3))

Third, the increase in \[Ca^2+^\]~c~ evoked by GPN was abolished by depleting the ER of Ca^2+^ by using CPA or thapsigargin to inhibit SERCAs ([Fig. 1](#JCS223883F1){ref-type="fig"}D,F). Thapsigargin had no effect on the GPN-evoked increases in pH~ly~ or pH~cyt~ ([Fig. S1H,I](Fig. S1H,I)). Although no SERCAs were detected in the proteome of lysosomal membranes ([@JCS223883C4]; [@JCS223883C8]), it has been suggested that a SERCA with reduced Ca^2+^ affinity, i.e. SERCA3, may contribute to Ca^2+^ uptake by acidic stores ([@JCS223883C27]). We, therefore, considered whether inhibition of GPN-evoked cytosolic Ca^2+^ signals by thapsigargin and CPA is due to direct inhibition of lysosomal Ca^2+^ sequestration. However, IP~3~-evoked Ca^2+^ release from the ER also massively and rapidly attenuated the cytosolic Ca^2+^ signals evoked by GPN ([Fig. S4](Fig. S4)). This confirms that loss of Ca^2+^ from the ER, rather than inhibition of SERCAs themselves, rapidly inhibits GPN-evoked increases in \[Ca^2+^\]~c~.

GPN does not stimulate Ca^2+^-induced Ca^2+^ release from the ER {#s2b}
----------------------------------------------------------------

Others have suggested that GPN-evoked Ca^2+^ release from lysosomes is amplified by Ca^2+^-induced Ca^2+^ release (CICR) by IP~3~Rs or ryanodine receptors (RyRs) in the ER, and that this accounts for the inhibition of GPN responses by thapsigargin ([@JCS223883C24]). Although HEK and HAP1 cells appear not to express functional RyRs ([Fig. S5A,B](Fig. S5A,B)) ([@JCS223883C56]), we confirmed that ryanodine (to inhibit RyRs) had no effect on the increase in \[Ca^2+^\]~c~ evoked by GPN ([Fig. S5C,D](Fig. S5C,D)). Complete loss of IP~3~Rs in HEK ([@JCS223883C1]) or HAP1 cells ([@JCS223883C2]) by means of CRISPR/Cas9 had no effect on the Ca^2+^ signals evoked by GPN. In each case, the response to GPN was abolished by thapsigargin ([Fig. 1](#JCS223883F1){ref-type="fig"}F, [Fig. S5E](Fig. S5E)).

Transmembrane coiled-coil domain 1 (TMCO1) is an ER membrane protein that oligomerises to form a Ca^2+^ pore as the ER overloads with Ca^2+^ ([Fig. 2](#JCS223883F2){ref-type="fig"}A) ([@JCS223883C60]). TMCO1 might, thereby, allow GPN-evoked Ca^2+^ release from lysosomes to be amplified. We failed, using CRISPR/Cas9, to achieve complete knockout of TMCO1 in HEK cells but, with TMCO1 expression reduced by 67±14% (Fig. 2B), we observed the expected increase in carbachol-evoked Ca^2+^ signals ([@JCS223883C60]). However, there was no effect on the increase in \[Ca^2+^\]~c~ evoked by GPN ([Fig. 2](#JCS223883F2){ref-type="fig"}C,D). We, therefore, conclude that none of the known mechanisms (RyR, IP~3~R and TMCO1) that can mediate CICR from the ER contributed to the GPN-evoked increase in \[Ca^2+^\]~c~. The results, so far, demonstrate that GPN increases pH~ly~ and \[Ca^2+^\]~c~, but they challenge the conventional explanations of these phenomena. Fig. 2.**CICR mediated by TMCO1 does not contribute to GPN-evoked increases in \[Ca^2+^\]~c~.** (A) TMCO1 has been proposed to oligomerise into a functional Ca^2+^-permeable channel as the ER loads with Ca^2+^ ([@JCS223883C60]). Hence, TMCO1 might be able to mediate CICR because Ca^2+^ released by other intracellular channels fuels ER Ca^2+^ uptake by SERCAs, leading to Ca^2+^ overload and opening of TMCO1. (B) Typical western blot showing expression of TMCO1 in HEK cells in which CRISPR/Cas9 was used to achieve a partial knockdown of TMCO1 (67±14%, *n*=4, mean±s.d.). Molecular mass markers (kDa) and protein loadings (μg) are shown. (C,D) Peak Ca^2+^ signals evoked by a maximally effective concentration of carbachol (C) or the indicated concentrations of GPN (D) in Ca^2+^-free HBS (mean±s.e.m., *n*=3). \**P*\<0.05, Student\'s *t*-test.

Effects of GPN on pH~ly~, pH~cyt~ and cytosolic Ca^2+^ do not require cathepsin C {#s2c}
---------------------------------------------------------------------------------

The effects of GPN are thought to require its proteolysis by cathepsin C ([Fig. 1](#JCS223883F1){ref-type="fig"}A), an enzyme that is widely assumed to be expressed mainly in lysosomes ([@JCS223883C41]; [@JCS223883C62]). This distribution of cathepsin C is invoked to suggest that GPN selectively targets lysosomes. Three approaches were adopted to assess the contribution of cathepsin C to the effects of GPN. We used CRISPR/Cas9 to generate HEK cells devoid of cathepsin C activity (HEK-CTSC-KO) ([Fig. 3](#JCS223883F3){ref-type="fig"}A-C). We used prolonged treatment with a selective peptide inhibitor of cathepsin C (Gly-Phe-DMK) ([@JCS223883C33]; [@JCS223883C42]), and demonstrated that it effectively inhibited enzyme activity in HEK cell lysates ([Fig. 3](#JCS223883F3){ref-type="fig"}B,C). We also used glycyl-[d]{.smallcaps}-phenylalanine ([d]{.smallcaps}-GPN), in which the [l]{.smallcaps}-phenylalanine of [l]{.smallcaps}-GPN (hitherto described as GPN) is replaced by [d]{.smallcaps}-phenylalanine, because [d]{.smallcaps}-GPN, unlike [l]{.smallcaps}-GPN, is not a substrate for cathepsin C ([@JCS223883C21]). Fig. 3.**Effects of GPN on pH~ly~ do not require cathepsin C.** (A) Western blot shows expression of cathepsin C and β-actin in wild-type (WT) HEK cells and after CRISPR/Cas9-mediated disruption of the cathepsin C genes (CTSC-KO). Protein loadings (µg) and positions of molecular mass markers (kDa) are shown. A representative for five similar blots is shown. (B) Cathepsin C activity, determined using a substrate (Gly-Arg-AMC) that fluoresces after proteolysis, was determined using whole-cell lysates from WT or CTSC-KO cells, alone or after treatment of cells with the cathepsin C inhibitor Gly-Phe-DMK (10 μM, 72 h, 37°C). Results show mean±s.d. for duplicate determinations. The green symbols are obscured by the overlying blue symbols. (C) Summary results (mean±s.e.m., *n*=3) from analyses similar to those in panel B show fluorescence recorded after 7 min. \**P*\<0.05, one-way ANOVA, with Tukey\'s multiple comparison test (see panel B for colour key). (D) Lysosomes of WT or CTSC-KO HEK cells were loaded with pH indicators by endocytosis of dextran conjugates (Oregon Green and fluorescein) or by incubation with LysoTracker Red (100 nM, 20 min). Fluorescence was recorded before or 200 s after addition of GPN or [d]{.smallcaps}-GPN (300 µM each). Scale bars: 10 μm. (E) Time courses of the changes in LysoTracker Red fluorescence (F/F~0~) after addition of GPN or [d]{.smallcaps}-GPN (solid bars) in WT and CTSC-KO cells. (F-H) Summary results (mean±s.e.m., *n*=5) from analyses similar to those in panel E show the fluorescence changes (F/F~0~) before and 200 s after addition of the indicated GPN (300 µM). \**P*\<0.05, Student\'s *t*-test relative to before GPN-treatment.

GPN caused the usual sustained increase in pH~ly~ in HEK cells without cathepsin C. Furthermore, in normal HEK cells, GPN and [d]{.smallcaps}-GPN caused indistinguishable increases in pH~ly~ ([Fig. 3](#JCS223883F3){ref-type="fig"}D-H). These results establish that the effects of GPN on pH~ly~ do not require cathepsin C activity. Neither loss of cathepsin C nor its pharmacological inhibition affected pH~cyt~ or the basal \[Ca^2+^\]~c~ in unstimulated cells ([Fig. 4](#JCS223883F4){ref-type="fig"}A,B). In addition, pharmacological inhibition of cathepsin C had no effect on the increase in pH~cyt~ or \[Ca^2+^\]~c~ evoked by addition of GPN ([Fig. 4](#JCS223883F4){ref-type="fig"}C,D). Furthermore, the concentration-dependent effects of GPN on pH~cyt~ and \[Ca^2+^\]~c~ were indistinguishable in HEK cells with and without endogenous cathepsin C ([Fig. 4](#JCS223883F4){ref-type="fig"}E,F). Finally, [d]{.smallcaps}-GPN, like GPN, caused the same concentration-dependent increases in pH~cyt~ and \[Ca^2+^\]~c~ as GPN ([Fig. 4](#JCS223883F4){ref-type="fig"}G,H). Fig. 4.**Effects of GPN on pH~cyt~, pH~ly~ and \[Ca^2+^\]~c~ do not require cathepsin C.** (A,B) Effects of the cathepsin C inhibitor Gly-Phe-DMK (10 µM, 72 h) and comparison of WT with CTSC-KO cells on pH~cyt~ (A) and \[Ca^2+^\]~c~ (B) of unstimulated HEK cells. Matched controls (Control or WT) are shown for each comparison (inhibitor or CTSC-KO). (C,D) Effects of the cathepsin C inhibitor (Gly-Phe-DMK, 10 µM, 72 h) on the changes in pH~cyt~ (ΔpH~cyt~, measured 30 s after GPN addition) and the peak increase in \[Ca^2+^\]~c~ (Δ\[Ca^2+^\]~c~) evoked by GPN. (E,F) Results of analyses similar to those shown in C,D, comparing the effects of GPN in WT and CTSC-KO cells. (G,H) Results of analyses similar to those shown in C,D, comparing the effects of GPN and [d]{.smallcaps}-GPN. Results (A-H) show means±s.e.m., *n*=3, each with 3 replicates.

LLOMe is a substrate of cathepsin C and, like GPN, it is a weak base but it is less membrane-permeable than GPN ([Table S1](Table S1)). We confirmed that LLOMe caused lysis of lysosomes only in cells expressing cathepsin C ([Fig. S6A](Fig. S6A)), which is consistent with published work ([@JCS223883C42]). LLOMe also caused the expected increase in pH~ly~ but it minimally affected pH~cyt~ and had no effect on \[Ca^2+^\]~c~ ([Fig. S6B-F](Fig. S6B-F)). These results demonstrate that the effects of GPN on pH~ly~, pH~cyt~ and \[Ca^2+^\]~c~ do not require cathepsin C, whereas LLOMe causes cathepsin C-mediated lysis of lysosomes without increasing \[Ca^2+^\]~c~.

Other weak bases evoke ER-dependent Ca^2+^ signals {#s2d}
--------------------------------------------------

GPN, but not [d]{.smallcaps}-GPN, is a substrate for cathepsin C; however, both are amphipathic weak bases ([Table S1](Table S1)), which, in common with other lysosomotropic agents, accumulate within lysosomes ([Fig. 5](#JCS223883F5){ref-type="fig"}A) ([@JCS223883C36]; [@JCS223883C58]). We, therefore compared the actions of GPN with those of NH~4~Cl, another lysosomotropic agent that is often used to increase pH~ly~ (e.g. [@JCS223883C22]), and with fluoxetine (the antidepressant known as Prozac), an unrelated structure that has similar physical properties (p*K~a~* and hydrophobicity) to GPN ([Fig. 5](#JCS223883F5){ref-type="fig"}A and [Table S1](Table S1)). Fig. 5.**Other weak bases evoke ER-dependent Ca^2+^ signals.** (A) Structures and mechanisms of action of some lysosomotropic drugs. (B) Confocal images of HEK cells loaded with LysoTracker Red (100 nM, 20 min) and then treated (200 s) with NH~4~Cl (20 mM) or fluoxetine (300 μM). (C) Quantification of fluorescence (F/F~0~) from images similar to those in panel B. Results show mean±s.e.m., *n*=7. F~0~ and F are fluorescence recorded before and 200 s after the addition of NH~4~Cl or fluoxetine. (D) Effects of NH~4~Cl (20 mM) or fluoxetine (300 μM) on pH~cyt~ recorded in populations of SNARF-5F-loaded HEK cells. Results show mean±s.d. of *n*=3 determinations. (E) Summary results (mean±s.e.m., *n*=3, each with 3 replicates) show peak increases in pH~cyt~ (ΔpH~cyt~). (F-H) Effects of thapsigargin (TG, 1 μM, 15 min) in Ca^2+^-free HBS on the Ca^2+^ signals evoked by [d]{.smallcaps}-GPN (200 μM) (F), fluoxetine (300 μM) (G) or NH~4~Cl (20 mM) (H). Results show mean±s.d. of *n*= 3 determinations. (I-K) Summary results from analyses similar to those in panels F-H show the effects of [d]{.smallcaps}-GPN (I), fluoxetine (J) or NH~4~Cl (K) on Δ\[Ca^2+^\]~c~ alone or after treatment with thapsigargin (TG, 1 μM, 15 min). Results show mean±s.e.m., *n*=3, each with 3 replicates. (L) A requirement for ER Ca^2+^ for GPN to evoke an increase in \[Ca^2+^\]~c~ might reflect a need for the ER to fuel lysosomal Ca^2+^ uptake (option 1) or a direct action of GPN on the ER (option 2).

As expected NH~4~Cl and fluoxetine caused rapid and sustained increases in pH~ly~ ([Fig. 5](#JCS223883F5){ref-type="fig"}B,C), but they also caused transient increases in pH~cyt~ and \[Ca^2+^\]~c~, similar to those evoked by GPN ([Fig. 5](#JCS223883F5){ref-type="fig"}D-K). Furthermore, the Ca^2+^ signals evoked by NH~4~Cl and fluoxetine, like those evoked by GPN and [d]{.smallcaps}-GPN, were abolished by pretreatment with thapsigargin ([Fig. 5](#JCS223883F5){ref-type="fig"}F-K). The increases in \[Ca^2+^\]~c~ evoked by NH~4~Cl and fluoxetine were similar in cells with and without IP~3~Rs ([Fig. S7A,B](Fig. S7A,B)). By using carbachol or thapsigargin to estimate the residual Ca^2+^ content of the ER (through stimulation of IP~3~ formation or inhibition of SERCAs, respectively), we confirmed that both GPN and NH~4~Cl caused a concentration-dependent decrease in the ER Ca^2+^ content ([Fig. S7C,D](Fig. S7C,D)). These results establish that four different weak bases (GPN, [d]{.smallcaps}-GPN, NH~4~Cl and fluoxetine) have similar effects. Each causes a sustained increase in pH~ly,~ and transient increases in pH~cyt~ and \[Ca^2+^\]~c~. The latter invariably requires Ca^2+^ within the ER, but requires neither IP~3~Rs nor RyRs.

GPN stimulates Ca^2+^ release from the ER by increasing pH~cyt~ {#s2e}
---------------------------------------------------------------

Since no known CICR mechanism contributes to the Ca^2+^ signals evoked by GPN ([Figs 1](#JCS223883F1){ref-type="fig"}F and [2](#JCS223883F2){ref-type="fig"}, [Fig. S5](Fig. S5)), the requirement for ER Ca^2+^ cannot arise from it amplifying an initial GPN-evoked Ca^2+^ release from lysosomes. However, we ([@JCS223883C2]; [@JCS223883C28]) and others ([@JCS223883C16]) have suggested that the ER also contributes to Ca^2+^ uptake by lysosomes ([Fig. 5](#JCS223883F5){ref-type="fig"}L). We, therefore, considered whether the primary action of GPN is to trigger Ca^2+^ release from lysosomes, which might be attenuated when lysosomes can no longer acquire Ca^2+^ from ER ([Fig. 5L](#JCS223883F5){ref-type="fig"}, option 1). Evidence that IP~3~-evoked Ca^2+^ release from the ER immediately attenuates responses to GPN ([Fig. S4](Fig. S4)) argues against this proposal, and subsequent experiments confirm that it is untenable.

After dissipation of the lysosomal pH gradient by sustained treatment with bafilomycin A~1~, the GPN-evoked increase in \[Ca^2+^\]~c~ was exaggerated ([Fig. 6](#JCS223883F6){ref-type="fig"}A,B), just as responses to Ca^2+^ release from the ER through IP~3~Rs or inhibition of SERCAs are exaggerated after treatment with bafilomycin A~1~ ([@JCS223883C2]; [@JCS223883C28]). Similar results were obtained after lysis of lysosomes by pre-treatment with LLOMe, namely the increase in \[Ca^2+^\]~c~ evoked by GPN was exaggerated ([Fig. 6](#JCS223883F6){ref-type="fig"}C,D). Hence, under conditions where GPN cannot cause an increase in pH~ly~ and when lysosomes are unable to accumulate Ca^2+^ ([@JCS223883C2]), GPN evokes larger increases in \[Ca^2+^\]~c~. We, therefore, considered whether the GPN-evoked increases in pH~cyt~ directly stimulate Ca^2+^ release from the ER ([Fig. 5](#JCS223883F5){ref-type="fig"}L*2*). Fig. 6.**Buffering the GPN-evoked increase in pH~cyt~ abolishes Ca^2+^ release from the ER.** (A) Effects of bafilomycin A~1~ (Baf A~1~, 1 μM, 1 h) on the Ca^2+^ signals evoked by GPN (200 μM) in HEK cells in Ca^2+^-free HBS. Mean±s.d. of 3 replicates. (B) Summary results (mean±s.e.m., *n*=4, each with 3 replicates) from analyses similar to those in panel A show peak increases in \[ΔCa^2+^\]~c~ evoked by GPN (Δ\[Ca^2+^\]~c~). \**P*\<0.05, Student\'s *t*-test. (C) Effects of pre-treating HEK cells with LLOMe (Leu-Leu-OMe; 1 mM, 1 h) on the Ca^2+^ signals evoked by GPN (200 μM) in Ca^2+^-free HBS. Mean±s.d. of 3 replicates. (D) Summary results (mean±s.e.m., *n*=4, each with 3 replicates) from analyses similar to those in panel C show peak increases in \[Ca^2+^\]~c~ evoked by GPN (Δ\[Ca^2+^\]~c~). \**P*\<0.05, Student\'s *t*-test. (E) HEK cells in Ca^2+^-free HBS were treated with sodium proprionate (NaP, 30 mM) before addition of GPN (200 μM). Results show pH~cyt~ (mean of 3 replicates). (F) Summary results (mean±s.e.m., *n*=3, each with 3 replicates) from analyses similar to those in panel E show pH~cyt~ measured 30 s or 2 min after GPN addition. \**P*\<0.05, Student\'s *t*-test. (G) Typical images of HEK cells showing the effects of NaP (30 mM, 30 min) and then GPN (200 μM, 30 s) on LysoTracker Red staining. (H) Time-course (mean±s.d., *n*= 3 cells). (I) Analysis of the effects of NaP and GPN on \[Ca^2+^\]~c~ (mean of 3 replicates). (J-L) Summary results \[mean±s.e.m., *n*=4 (J) or *n*=3 (K,L), each with 3 replicates\] from analyses similar to those in panel E show peak Ca^2+^ signals (Δ\[Ca^2+^\]~c~) evoked by GPN (200 μM), carbachol (CCh, 1 mM) or ionomycin (5 μM) in Ca^2+^-free HBS. \**P*\<0.05, Student\'s *t*-test.

We loaded HEK cells with sodium proprionate (NaP), a weak acid, to buffer changes in pH~cyt~ evoked by GPN. NaP caused an initial drop in pH~cyt~ that slowly recovered, and subsequent addition of GPN caused an attenuated increase in pH~cyt~ ([Fig. 6](#JCS223883F6){ref-type="fig"}E). The immediate effect of GPN on pH~cyt~ was only modestly attenuated by NaP, but after 2 min the response was reduced by \>60% ([Fig. 6](#JCS223883F6){ref-type="fig"}F). NaP did not affect pH~ly~ or prevent GPN from rapidly increasing pH~ly~ ([Fig. 6](#JCS223883F6){ref-type="fig"}G,H). The GPN-evoked increase in \[Ca^2+^\]~c~, which takes 106±2 s to reach its peak ([Fig. 1](#JCS223883F1){ref-type="fig"}G, [Fig. S1C](Fig. S1C)), was almost abolished by NaP ([Fig. 6](#JCS223883F6){ref-type="fig"}I,J). NaP had no effect on the increase in \[Ca^2+^\]~c~ evoked by carbachol or the Ca^2+^ content of the intracellular stores assessed by addition of ionomycin ([Fig. 6](#JCS223883F6){ref-type="fig"}K,L). These results demonstrate that an increase in pH~cyt~ is required for GPN to increase \[Ca^2+^\]~c~, whereas an increase in pH~ly~ is ineffective ([Fig. 7](#JCS223883F7){ref-type="fig"}). Fig. 7.**GPN evokes Ca^2+^ release from the ER through an increase in pH~cyt~.** GPN, a weak membrane-permeant base, causes pH~cyt~ to transiently increase which directly stimulates Ca^2+^ release from the ER through a mechanism that requires neither IP~3~Rs nor RyRs. Some of the Ca^2+^ released by this pH-regulated mechanism, similarly to Ca^2+^ released by IP~3~Rs, is then accumulated by lysosomes (LY). Many physiological stimuli that increase pH~cyt~, including those that stimulate the Na^+^/H^+^ antiporter (NHE) through protein kinase C (PKC), evoke increases in \[Ca^2+^\]~c~ through the same pathway.

DISCUSSION {#s3}
==========

GPN is used extensively to perturb lysosomes and, as interest in the contributions of lysosomes to Ca^2+^ signalling has grown, has been widely used to release Ca^2+^ from lysosomes (see Introduction). It has been universally assumed that GPN achieves selectivity for lysosomes because its cleavage by the lysosomal enzyme cathepsin C causes osmotic stress that ruptures lysosomal membranes ([Fig. 1](#JCS223883F1){ref-type="fig"}A). Our results challenge these assumptions and demonstrate that GPN does not selectively target lysosomes.

We have shown that GPN does not acutely rupture lysosomes ([Fig. 1](#JCS223883F1){ref-type="fig"}B,C,K,L, [Fig. S3](Fig. S3)) and that it causes a transient increase in pH~cyt~ ([Fig. 1](#JCS223883F1){ref-type="fig"}I,J, [Fig. S1E,F](Fig. S1E,F)). GPN also increases pH~ly~ and \[Ca^2+^\]~c~. None of these effects of GPN require cathepsin C ([Figs 3](#JCS223883F3){ref-type="fig"} and [4](#JCS223883F4){ref-type="fig"}). The GPN-evoked increase in \[Ca^2+^\]~c~ is mediated by Ca^2+^ release from the ER, without any evident involvement of lysosomes: Ca^2+^ signals are abolished by depleting the ER of Ca^2+^ ([Figs 1](#JCS223883F1){ref-type="fig"}D,F and [5](#JCS223883F5){ref-type="fig"}F-K, [Figs S4 and S5E](Figs S4 and S5E)), amplified when lysosomes are no longer acidified ([Fig. 6](#JCS223883F6){ref-type="fig"}A,B), and show no requirement for CICR from the ER ([Figs 1](#JCS223883F1){ref-type="fig"}F and [2](#JCS223883F2){ref-type="fig"}, [Fig. S5](Fig. S5)).

Several lines of evidence show that the GPN-evoked increase in pH~cyt~ stimulates Ca^2+^ release from the ER ([Fig. 7](#JCS223883F7){ref-type="fig"}). Other membrane-permeant weak bases mimic GPN ([Fig. 5](#JCS223883F5){ref-type="fig"}, [Fig. S7](Fig. S7)), depletion of the ER of Ca^2+^ abolishes the GPN-evoked increase in \[Ca^2+^\]~c~ ([Figs 1](#JCS223883F1){ref-type="fig"}D-F and [5](#JCS223883F5){ref-type="fig"}F-K, [Figs S4 and S5E](Figs S4 and S5E)) without affecting the pH~cyt~ increase ([Fig. S1I](Fig. S1I)), and an increase in pH~ly~ is not required for GPN to release Ca^2+^ ([Fig. 6](#JCS223883F6){ref-type="fig"}A,B). Furthermore, rupture of lysosomes with LLOMe exaggerates, rather than prevents, cytosolic Ca^2+^ signals evoked by GPN ([Fig. 6](#JCS223883F6){ref-type="fig"}C,D, [Fig. S6](Fig. S6)). Finally, GPN-evoked Ca^2+^ release is almost abolished when the pH~cyt~ changes are buffered under conditions where GPN still causes an increase in pH~ly~ ([Fig. 6](#JCS223883F6){ref-type="fig"}). We conclude that GPN, and other membrane-permeant weak bases, cause an increase in pH~cyt~, which then stimulates Ca^2+^ release from the ER ([Fig. 7](#JCS223883F7){ref-type="fig"}).

Cells tightly control their pH~cyt~, passively with buffers and actively by means of ion transporters ([@JCS223883C7]), but many stimuli cause acute increases in pH~cyt~ at least as large as those evoked by GPN (ΔpH=0.37±0.06, [Fig. 1](#JCS223883F1){ref-type="fig"}H). The stimuli include those that activate the plasma membrane Na^+^-H^+^ exchanger (NHE) through protein kinase C ([@JCS223883C59]) and signals that prepare sperm for fertilisation ([@JCS223883C3]). Furthermore, in tumours, pH~cyt~ is often increased ([@JCS223883C48]). In many cell types, an increase in pH~cyt~ increases \[Ca^2+^\]~c~. In some cells, the response requires Ca^2+^ entry ([@JCS223883C17]; [@JCS223883C59]) but in many others it is due to Ca^2+^ release from intracellular stores, most likely the ER ([@JCS223883C5]; [@JCS223883C49]; [@JCS223883C50]; [@JCS223883C51]; [@JCS223883C61]; [@JCS223883C63]). The mechanisms are unknown and, since the pH of the ER lumen (pH~ER~) is assumed to equilibrate rapidly with pH~cyt~ ([@JCS223883C7]), the effect might be exercised from the cytosol or ER lumen. Because increased pH~ER~ would be expected to increase Ca^2+^ buffering and so decrease ER luminal free \[Ca^2+^\], the Ca^2+^ release evoked by increased pH~cyt~ is probably due to the opening of a Ca^2+^-permeable ER channel. At increased pH~cyt~, phospholipase C may be stimulated ([@JCS223883C63]) and IP~3~ also binds more tightly to IP~3~Rs ([@JCS223883C23]), but GPN-evoked Ca^2+^ release does not require IP~3~Rs ([Fig. 1](#JCS223883F1){ref-type="fig"}F, [Fig. S5E](Fig. S5E)). SERCAs, which transport Ca^2+^ in exchange for H^+^, are inhibited by increased pH ([@JCS223883C25]; [@JCS223883C30]). However, inhibition of SERCAs cannot explain our results because the Ca^2+^ release evoked by GPN was both faster and more substantial than that evoked by inhibition of SERCAs by CPA or thapsigargin ([Fig. 1](#JCS223883F1){ref-type="fig"}D,G, [Fig. S1D](Fig. S1D)). Hence, modest increases in pH~cyt~, similar to those evoked by many physiological stimuli, trigger a substantial Ca^2+^ release from the ER that requires neither RyRs nor IP~3~Rs.

We conclude that GPN does not, as hitherto supposed, evoke Ca^2+^ release from lysosomes through its cathepsin C-mediated proteolysis. Instead, GPN, in common with other membrane-permeant weak bases and many physiological stimuli, transiently increases pH~cyt~, and that directly stimulates Ca^2+^ release from the ER by a mechanism that is independent of known ER Ca^2+^ release channels.

MATERIALS AND METHODS {#s4}
=====================

Materials {#s4a}
---------

SNARF-5F, dextran-conjugates of Oregon Green 488 (*M*~r~ 10,000), Alexa Fluor-488 (*M*~r~ 10,000 and 3000) or fluorescein (*M*~r~ 3000), LysoTracker Red DND-99, Lucifer Yellow, Platinum Pfx DNA polymerase, Tris-acetate SDS running buffer, 4--12% Bis-Tris polyacrylamide gels, iBLOT transfer kit, custom primers, EDTA-free Pierce protease inhibitor mini-tablets, Rapid DNA ligation kit, and Spectra multicolour broad range protein ladder were from ThermoFisher (Waltham, MA). Glycyl-[l]{.smallcaps}-phenylalanine 2-naphthylamide (GPN) was from Bachem (St. Helens, UK) and Santa Cruz Biotechnology (Dallas, TX); most experiments used GPN from Bachem (see [Fig. S1E,F](Fig. S1E,F)). Glycyl-[d]{.smallcaps}-phenylalanine 2-naphthylamide ([d]{.smallcaps}-GPN) was custom-synthesised by LifeTein (Somerset, NJ). Gly-Arg-7-amino-4-methylcoumarin (Gly-Arg-AMC) was from Bachem. Gly-Phe-diazomethylketone (Gly-Phe-DMK) was from MP Bio (Derby, UK). Fibronectin was from Merck Millipore (Watford, UK). ECL prime western blotting detection reagent was from GE Life Sciences (Little Chalfont, UK). Thapsigargin and cyclopiazonic acid (CPA) were from Bio-Techne (Minneapolis, MN). Fluo 8-AM was from Stratech Scientific (Suffolk, UK). 1,2-bis(O-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA) was from Phion (Dorset, UK). Ionomycin was from Apollo Scientific (Stockport, UK). Ryanodine, Pluronic F-127, sodium propionate (NaP), fluoxetine hydrochloride, Leu-Leu methyl ester hydrobromide (Leu-Leu-OMe) and carbamylcholine chloride (carbachol, CCh) were from Sigma (Dorset, UK).

Cell culture {#s4b}
------------

HEK and HeLa cell lines were cultured in Dulbecco\'s modified Eagle's medium (DMEM)/F-12 with GlutaMAX (ThermoFisher) supplemented with foetal bovine serum (FBS, 10%, Sigma) at 37°C in humidified air with 5% CO~2~. HEK cells lacking all IP~3~R subtypes (HEK-IP~3~R-KO) were from Kerafast (Boston, MA) ([@JCS223883C1]). HAP1 cells, genetically engineered using CRISPR/Cas9 to disrupt genes for all three IP~3~R subtypes, were developed with Horizon Discovery (Cambridge, UK) ([@JCS223883C2]). HAP1 cells were cultured in Iscove\'s modified Dulbecco\'s medium (IMDM) GlutaMAX (ThermoFisher) with 10% FBS. The cells were maintained at 37°C in humidified air with 5% CO~2~. Cells were passaged every 3--4 days using GibcoTrypLE Express (ThermoFisher). All cell lines were confirmed to be free of mycoplasma.

For imaging, cells were grown on glass-bottomed dishes (35-mm with a 7-mm No. 0 glass insert, MatTek Corporation, Ashland, MA) coated with human fibronectin (10 µg/ml). BacMam baculovirus encoding human M~3~ muscarinic acetylcholine receptors (M~3~Rs) was produced as described ([@JCS223883C52]). HEK cells were infected at a multiplicity of infection (MOI) of ∼50 and used after 48 h ([Fig. S4](Fig. S4)).

Generation of HEK cells without cathepsin C {#s4c}
-------------------------------------------

CRISPR/Cas9 was used to disrupt the genes encoding cathepsin C (CTSC). Guide sequences were selected using E-crispr.org ([@JCS223883C20]) and zitfit.partners.org ([@JCS223883C46]). Oligonucleotides encoding four different guide RNAs (sgRNA) were used to target the first, second and third exons of CTSC (sgRNAs for exon 1: 5′-GCTGGGCACCTGGGTCTTCC-3′ and 5′-GCCCTCCTGCTGCTTCTCTC-3′; sgRNA for exon 2: GATACAGCATATGATGACCT-3′; sgRNAs for exon 3: 5′-GTTGACATACACATTCTCAG-3′). Each guide and its complementary sequence had a sticky end (5′-CACC-3′ or 5′-AAAC-3′) to allow ligation into the Px458 vector, which also encodes Cas9 nuclease and GFP (Addgene \#[48138](48138)) ([@JCS223883C40]). The coding sequences of the four final plasmids were verified. HEK cells were transfected with pX458-sgRNAs using Trans LT1 (4 µg DNA per 6-well plate). After 48 h, EGFP-expressing cells were sorted as single cells into 96-well plates by fluorescence-activated cell sorting (FACS). After 8 weeks, clones were screened by western blotting. The HEK-CTSC-KO cells express no detectable cathepsin C activity ([Fig. 3](#JCS223883F3){ref-type="fig"}A-C).

Generation of HEK cells deficient in TMCO1 {#s4d}
------------------------------------------

The methods used to generate cells deficient in TMCO1 were the same as those used to generate HEK-CTSC-KO cells. The only effective sgRNA (5′-GAAGCGGAAGTGCGATCTTC-3′) targeted exon 1. Neither different sgRNAs, targeting exon 1 (5′-GTGCACGGCTCTGCTCGCAG-3′) or exon 3 (5′-GAAACAATAACAGAGTCAGC-3′ and 5′-GTTTACAGTGGAAAAGAAGA-3′), nor repeated transfections with multiple sgRNAs succeeded in yielding cells with both TMCO1 alleles disrupted ([Fig. 2](#JCS223883F2){ref-type="fig"}).

Measurements of pH~cyt~ in cell populations {#s4e}
-------------------------------------------

Confluent cultures of cells grown in 96-well plates (Greiner Bio-One, Storehouse, UK) were loaded with the ratiometric pH indicator SNARF-5F ([@JCS223883C26]) by incubation (30 min, 20°C) with SNARF-5F AM (2 µM, 30 min) in HEPES-buffered saline (HBS) containing Pluronic F-127 (0.02%). HBS had the following composition: 135 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl~2~, 1.5 mM CaCl~2~, 11.5 mM glucose, 11.6 mM HEPES pH 7.3. Cells were washed in HBS, and fluorescence was recorded from cells in HBS at 20°C at intervals of 3.8 s (excitation, 543 nm; emission, 580 and 640 nm) using a FlexStation 3 fluorescence plate-reader with SoftMaxPro software (MDS Analytical Technologies, Wokingham, UK). Fluorescence was calibrated to pH~cyt~ from where, p*K~a~* is the negative log of the acid-base dissociation constant (*K~a~*); R is the fluorescence emission ratio (F~580~:F~640~); R~a~ (F~a~) and R~b~ (F~b~) are the fluorescence ratios (or fluorescence intensities at 640 nm) for the fully protonated and de-protonated forms of the indicator.

To determine the p*K~a~* of SNARF-5F, cells loaded with SNARF-5F were treated for 30 min in Ca^2+^-free cytosol-like medium (CLM pH 7.4) with the H^+^/K^+^ antiporter nigericin (50 µM). CLM was then replaced by CLM supplemented with nigericin (50 µM) and buffered at different pH values (pH 5.0--8.5), and SNARF-5F fluorescence was measured. Ca^2+^-free CLM had the following composition: KCl 140 mM, NaCl 4 mM, MgCl~2~ 1.4 mM, HEPES 10 mM, EGTA 1 mM. The resulting calibration plot of pH versus had a slope of ∼1 and the intercept was the p*K*~a~ (7.09) used in all further calibrations.

Measurements of \[Ca^2+^\]~c~ in cell populations {#s4f}
-------------------------------------------------

For measurements of cytosolic free \[Ca^2+^\] (\[Ca^2+^\]~c~), confluent cell monolayers grown in 96-well plates were loaded with fluo 8 by incubation for 1 h at 20°C in HBS (100 μl) containing fluo 8-AM and 0.02% Pluronic F-127. Cells were then washed and incubated in HBS for 1 h at 20°C before use. CaCl~2~ was omitted from nominally Ca^2+^-free HBS, and in some experiments (see figure legends) BAPTA (final concentration 2.5 mM) was added to the HBS immediately before stimulation to reduce the free \[Ca^2+^\] of the HBS to \<20 nM. Fluorescence was recorded using a FlexStation 3 fluorescence plate-reader. Fluorescence was recorded at 1.44-s intervals, with excitation at 485 nm and emission at 525 nm. Data were collected and analyzed using SoftMax Pro software. Maximal (F~max~) and minimal (F~min~) fluorescence values were determined from parallel wells after addition of Triton X-100 (0.1%) with either 10 mM CaCl~2~ (F~max~) or 10 mM BAPTA (F~min~). Fluorescence values (F) were calibrated to \[Ca^2+^\]~c~ using a *K*~d~=389 nM (fluo 8) from

Loading lysosomes with fluorescent indicators {#s4g}
---------------------------------------------

To load lysosomes by endocytosis with fluorescent dyes, cells grown on poly-[l]{.smallcaps}-lysine-coated, glass-bottomed 35-mm dishes were incubated (16 h, 37°C) in culture medium supplemented with either a dextran-conjugated indicator (0.1 mg/ml) or Lucifer Yellow (0.2 mg/ml). After a further 4--6 h in the same medium without indicator, cells were used for experiments. For HEK cells expressing LAMP1-mCherry ([Fig. S3](Fig. S3)) ([@JCS223883C28]), confluent cells were transfected using TransIT-LT1 reagent (2.5 µg DNA in 7.5 µl reagent per 35-mm dish; GeneFlow, Lichfield, UK) at the same time as they were loaded with dextran-conjugated Alexa Fluor 488 (*M*~r~ ∼10,000). For labelling with LysoTracker Red, cells were incubated in HBS with LysoTracker Red DND-99 (100 nM, 20°C). After 20 min, cells were washed three times with HBS and used immediately.

Fluorescence microscopy {#s4h}
-----------------------

Fluorescence microscopy used inverted Olympus IX83 microscopes with 100× objectives (numerical aperture, NA 1.45 or 1.49), a multi-line laser bank (488 and 561 nm) and an iLas^2^ targeted laser illumination system (Cairn, Faversham, UK). Excitation light was transmitted through a quad dichroic beam-splitter (TRF89902-QUAD), and emitted light was passed through appropriate filters (Cairn Optospin). Wide-field images were collected with either an iXon Ultra 897 EMCCD camera (Andor, Belfast, Northern Ireland) or a 95B Scientific CMOS camera (Photometrics, Tuczon, AZ, USA) and MetaMorph microscopy automation and image analysis software (Molecular Devices). Bright-field images were acquired using a Cairn MonoLED illuminator.

Fluorescence from Oregon Green, fluorescein and Alexa Fluor 488 was excited at 488 nm and captured using a 525/50-nm filter (peak/bandwidth). LysoTracker Red and mCherry were excited at 561 nm and captured at 630/75 nm. All fluorescence images were corrected for background by subtraction of fluorescence from a region outside the cell.

Analysis of fluorescence images {#s4i}
-------------------------------

Time-lapse recordings of cells loaded with dextran-conjugated indicators were analyzed by taking randomly selected regions of interest (ROI) large enough for each to include several lysosomes (ROI, 3.2 µm×3.2 µm). Fluorescence changes were then expressed as F/F~0~, where F~0~ and F denote the average fluorescence within the ROI at the start of the experiment (F~0~) and at each subsequent time point (F).

To analyse the number of lysosomes in cells before and after GPN treatment ([Fig. 1](#JCS223883F1){ref-type="fig"}L), the Fiji TrackMate plugin ([@JCS223883C55]) was used to identify lysosomes as spots in background-corrected wide-field images.

For analysis of Alexa Fluor 488-dextran distribution in cells expressing LAMP1-mCherry, the FFT bandpass filter and thresholding functions in Fiji ([@JCS223883C47]) were used to generate a binary image to identify ROIs expressing LAMP1-mCherry (10--1000 pixels with a circularity of 0.1--1). Within the identified ROIs, the background-corrected fluorescence images for LAMP1-mCherry and Alexa Fluor 488 were used to compute a fluorescence ratio for each ROI (F~488~:F~561~). The F~488~:F~561~ values for all ROIs within each cell (typically 70--270, but ranging from 33--486) were averaged for each image, and then expressed relative to the value determined before treatment ([Fig. S3](Fig. S3)). This averaging within a cell was required because lysosomes move during the 25-min recording interval, making it impossible to track individual ROIs in recordings that were collected at 5-min intervals (to minimise photobleaching).

Western blots {#s4j}
-------------

Cells in 6-well plates were washed, lysed in RIPA buffer (30 μl, 4°C, 1 h) by using a syringe needle and sonication, and the supernatant (14,000 ***g***, 15 min, 4°C) was used for analysis.

RIPA buffer comprised: 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris pH 8. Protein samples were separated on 4--12% Bis-Tris PAGE gels, transferred to a polyvinyl difluoride (PVDF) membrane using an iBLOT system, and blocked by incubation in TBST with gentle shaking (1 h, 20°C). Tris-buffered saline (TBS) comprised: 150 mM NaCl, 50 mM Tris pH 7.5. For TBST, TBS was supplemented with 0.1% Tween-20 and 5% BSA. The membrane was washed with TBST, incubated with primary antibody (16 h, 40°C), washed with TBST (3×5 min, 20°C), incubated with HRP-conjugated secondary antibody in TBST with 1% BSA (1 h, 20°C), and washed with TBST (3×5 min, 20°C). Enhanced chemiluminescence (ECL) primer western blotting detection reagent (Amersham, UK) and a Syngene PXi chemiluminescence detection system were used to detect HRP. The antibodies used were mouse anti-cathepsin C (Santa Cruz Inc., Cat\# s74590, 1:500), rabbit anti-TMCO1 (Sigma, Cat\# AV49429, 1:1000), mouse anti β-actin (Cell Signaling, Cat\# 8H10D10, 1:1000), donkey anti-mouse IgG-HRP (Santa Cruz Inc., Cat\# sc-2314, 1:2000) and donkey anti-rabbit IgG-HRP (Santa Cruz Inc., Cat\# sc-2313, 1:5000).

Measurement of cathepsin C activity {#s4k}
-----------------------------------

Cathepsin C activity was measured by using a substrate, Gly-Arg-AMC, that becomes fluorescent after its proteolytic cleavage ([@JCS223883C14]; [@JCS223883C19]). HEK cell lysates were diluted in assay buffer (25 mM MES, 50 mM NaCl, 5 mM DTT, pH 6) to provide a protein concentration of 200 µg/ml, and distributed into 96-well plates (50 µl/well). Cleavage of Gly-Arg-AMC (50 µM) was monitored at 0.2-min intervals (excitation, 380 nm; emission 460 nm) using a FlexStation 3 plate-reader and SoftMax Pro software. A substrate blank was included as a control.

Statistical analysis {#s4l}
--------------------

Results are presented as means±s.e.m. or ±s.d., with *n* describing the number of independent analyses. Student\'s *t*-test, one-way or two-way ANOVA with Tukey\'s or Bonferroni test were used to determine statistical significance. *P*\<0.05 was considered statistically significant.
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